Teladoc Health, Inc.

TDOC

Teladoc Health, Inc. is a leading provider of virtual healthcare services, offering telemedicine solutions that enable patients to consult with healthcare professionals remotely. Founded in 2002, the company provides a range of digital health services, including general medical, mental health, and dermatology consultations, aiming to improve access to quality healthcare through technology.

$7.59 -0.02 (-0.26%)
🚫 Teladoc Health, Inc. does not pay dividends

Company News

Dialectical Behavior Therapy Market Set to Surge at 9.67% CAGR by 2034, Rising Adoption and Technological Advancements
GlobeNewswire Inc. • Towards Healthcare • November 12, 2025

The global dialectical behavior therapy market is projected to grow from USD 1.31 billion in 2025 to USD 3.29 billion by 2034, driven by rising mental health awareness, technological advancements, and expanding digital therapy platforms.

Is This Beaten-Down Stock Finally on the Road to Recovery?
The Motley Fool • Prosper Junior Bakiny • November 4, 2025

Teladoc Health continues to struggle with declining revenue and profitability challenges, despite potential growth opportunities in mental health services and international expansion. The stock remains unattractive to investors due to competitive landscape and uncertain growth prospects.

Teladoc Health Acquires Telecare, Expanding Access to Specialist and Allied Health Care for Australians in Public and Private Health
Benzinga • Globe Newswire • August 14, 2025

Teladoc Health has acquired Telecare, an Australian virtual care provider with over 300 specialists across 30 specialties, to expand its international healthcare services and improve access to specialist care in Australia.

Hims & Hers (HIMS) Gains 45.8% in Three Months: What's Next?
Zacks Investment Research • Zacks Investment Research • August 5, 2024

Hims & Hers Health, Inc. (HIMS) has seen a 45.8% stock price increase in the past three months, outperforming the industry and broader market. The company's recent announcements, including the addition of GLP-1 injections to its weight loss portfolio and positive 2024 revenue outlook, have contributed to the stock's upward momentum.

Cathie Wood's ARK adjusts, buys CrowdStrike stock, sells Tesla By Investing.com - Investing.com Canada
Investing.com • Investing.Com • July 23, 2024

Cathie Wood's ARK ETFs made significant portfolio adjustments, selling Teladoc shares, increasing CrowdStrike holdings, and reducing Tesla positions.

Related Companies